|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/472 | |||
| C07B 45/04 |
| (11) | Patento numeris | 3197454 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15844846.4 |
| Europos patento paraiškos padavimo data | 2015-09-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/052320 |
| Data | 2015-09-25 |
| (87) | Numeris | WO 2016/049509 |
| Data | 2016-03-31 |
| (30) | Numeris | Data | Šalis |
| 201462055286 P | 2014-09-25 | US |
| (72) |
TWEEDIE, Scott, US
VENKATRAMAN, Sripathy, US
LIU, Shuhong, US
ZELLER, James, US
BROT, Elisabeth, US
HAMLIN, Michael, US
NEWMAN, Mary, US
MCLAWS, Mark, US
ROSENBERG, John, US
LATHBURY, David, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | CONTINUOUS FLOW CARBOXYLATION REACTION |
| CONTINUOUS FLOW CARBOXYLATION REACTION |